EverydayHealthLogo
Dr. Richard Hoppe, MD

Dr. Richard Hoppe, MD

Pleasanton, CA

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Hoppe, Radiation Oncologist in Pleasanton, CA?

    Dr. Richard Hoppe, MD is a Radiation Oncologist, who primarily practices in Pleasanton, CA with 2 additional practice locations. He is board certified by the American Board of Radiology. Dr. Hoppe completed his residency at Stanford Univ Hosp, Therapeutic Radiology North Shore Univ Hosp, Internal Medicine. Dr. Hoppe is fluent in English, and is currently seeing new patients. Dr. Hoppe’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Hoppe’s office.

    Where did Dr. Hoppe go to medical school and complete their residency?

    • Residency: Stanford Univ Hosp, Therapeutic Radiology North Shore Univ Hosp, Internal Medicine | Stanford University School of Medicine

    Is Dr. Hoppe board certified in Radiation Oncologist?

    Yes, Dr. Richard Hoppe, MD is board certified by the American Board of Radiology , American Board of Radiology since 1976

    What languages does Dr. Hoppe speak?

    Dr. Hoppe and their clinical team can communicate with patients in the following languages:

    • English

    What conditions does Dr. Hoppe treat?

    As a Radiation Oncologist, Dr. Hoppe diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Hoppe. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Mycosis Fungoides
    • MALT Lymphoma
    • Follicular Lymphoma
    • Diffuse Large B-cell Lymphoma
    • Lymphoma
    • Non-Hodgkin Lymphoma
    • Mycosis fungoides
    • Cutaneous T-cell lymphoma
    • CTCL
    • Alibert-Bazin syndrome
    • Mucosa-associated lymphoid tissue lymphoma
    • Extranodal marginal zone lymphoma
    • B-cell lymphoma
    • NHL
    • Follicular Lymphatic Cancer
    • Indolent Lymphoma
    • DLBCL
    • Aggressive B-cell Lymphoma
    • Diffuse B-cell Lymphoma
    • Lymphatic Cancer
    • Lymphosarcoma
    • Lymphoma in Organs

    ICD-10 Codes:

    • C8409: Mycosis fungoides, extranodal and solid organ sites
    • C884: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
    • C8205: Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb
    • C8339: Diffuse large B-cell lymphoma, extranodal and solid organ sites
    • C8400: Mycosis fungoides, unspecified site
    • C8209: Follicular lymphoma grade I, extranodal and solid organ sites
    • C8580: Other specified types of non-Hodgkin lymphoma, unspecified site
    • C8589: Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites
    • C8201: Follicular lymphoma grade I, lymph nodes of head, face, and neck

    Also known as:

    • Acute Myeloid Leukemia in Remission
    • Acute Lymphocytic Leukemia in Remission
    • Acute Myeloid Leukemia
    • Acute Lymphocytic Leukemia
    • AML Leukemia in Remission
    • Acute Myeloblastic Leukemia in Remission
    • Acute Myelogenous Leukemia in Remission
    • ALL Leukemia in Remission
    • Acute Lymphoblastic Leukemia in Remission
    • Childhood Leukemia in Remission
    • AML Leukemia
    • Acute Myeloblastic Leukemia
    • Acute Myelogenous Leukemia

    ICD-10 Codes:

    • C9201: Acute myeloblastic leukemia, in remission
    • C9101: Acute lymphoblastic leukemia, in remission
    • C9200: Acute myeloblastic leukemia, not having achieved remission

    Also known as:

    • Nodular Sclerosis Hodgkin Lymphoma in Chest Lymph Nodes
    • Hodgkin Lymphoma
    • Nodular Sclerosis Hodgkin Lymphoma (Multiple Lymph Nodes)
    • NSHL in Chest', 'Hodgkin's Lymphoma in Intrathoracic Lymph Nodes
    • Hodgkin's Disease', 'Hodgkin's Lymphoma
    • NSHL widespread', 'Nodular sclerosing Hodgkin's disease in many lymph nodes

    ICD-10 Codes:

    • C8112: Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes
    • C8190: Hodgkin lymphoma, unspecified, unspecified site
    • C8118: Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites

    Also known as:

    • Multiple Myeloma
    • Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
    • Active multiple myeloma
    • Untreated multiple myeloma
    • Plasma cell myeloma

    ICD-10 Codes:

    • C9000: Multiple myeloma not having achieved remission

    Also known as:

    • Prostate Cancer
    • Prostate Cancer Treatment (PDQ®)
    • Prostatic Carcinoma
    • Prostate Gland Cancer
    • Malignant Prostate Tumor

    ICD-10 Codes:

    • C61: Malignant neoplasm of prostate

    Also known as:

    • Aplastic Anemia
    • Bone Marrow Failure Anemia
    • Marrow Aplasia

    ICD-10 Codes:

    • D619: Aplastic anemia, unspecified

    Also known as:

    • Myelodysplastic Syndrome
    • Myelodysplastic Syndromes
    • Myelodysplastic Syndromes Treatment (PDQ®)
    • MDS
    • Preleukemia
    • Bone marrow failure disorder

    ICD-10 Codes:

    • D469: Myelodysplastic syndrome, unspecified

    Also known as:

    • Secondary Bone Cancer
    • Bone Cancer
    • Metastatic bone cancer
    • Cancer spread to bone
    • Bone metastases

    ICD-10 Codes:

    • C7951: Secondary malignant neoplasm of bone

    Which procedures does Dr. Hoppe perform as a Radiation Oncologist?

    As a Radiation Oncologist, procedures performed by a Dr. Richard Hoppe may include:

    For detailed information, please contact Dr. Hoppe's office.

    Does Dr. Hoppe accept my insurance?

    Dr. Hoppe accepts most major insurance plans. Important: Please call our office at before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Hoppe accept in Pleasanton, CA?

    Dr. Hoppe in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Alignment Health Plan

    • All Other Third Party

    • Blue Shield of California

    • Care N' Care

    • CVS Health (formerly Aetna)

    • Department of Veterans Affairs

    • Kaiser Permanente

    • Medicare

    • Santa Clara Family Health Plan

    • UnitedHealthcare

    View All Insurances

    Where is Dr. Hoppe's office located?

    Dr. Richard Hoppe's Primary Practice

    5725 W Las Positas Blvd

    Pleasanton, CA 94588

    Get Directions

    Dr. Richard Hoppe's Practice 2

    875 Blake Wilbur Dr Rm CC-G224

    Palo Alto, CA 94304

    (650) 723-5510

    Get Directions

    Dr. Richard Hoppe's Practice 3

    300 Pasteur Dr

    Stanford, CA 94305

    Get Directions

    Recognitions

    Publications

    STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    In Situ Vaccition With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

    JOURL OF CLINICAL ONCOLOGY, 2010

    Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells

    AMERICAN JOURL OF CLINICAL PATHOLOGY, 2009

    Prognostic Factors in Primary Cutaneous Apl

    ARCHIVES OF DERMATOLOGY, 2009

    Low Stage Follicular Lymphoma

    AMERICAN JOURL OF SURGICAL PATHOLOGY, 2009

    Dymic CD8 T-Cell Responses to Tumor

    ONCOLOGY RESEARCH, 2009

    Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008

    Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008

    Hodgkin disease/lymphoma.

    Jourl of the tiol Comprehensive Cancer Network, 2008

    Tolerance and chimerism after rel and hematopoietic-cell transplantation.

    New England jourl of medicine, 2008

    Impact of positive positron emission tomography on prediction of freedom from progression after

    JOURL OF CLINICAL ONCOLOGY, 2007

    Revised response criteria for malignt lymphoma

    JOURL OF CLINICAL ONCOLOGY, 2007

    Screening for corory artery disease after mediastil irradiation for Hodgkin's disease

    JOURL OF CLINICAL ONCOLOGY, 2007

    Second lymphomas and other malignt neoplasms

    ARCHIVES OF DERMATOLOGY, 2007

    Protective conditioning for acute graft-versus-host disease

    NEW ENGLAND JOURL OF MEDICINE, 2005

    A technique of bone marrow collection from vertebral bodies of cynomolgus macaques

    JOURL OF SURGICAL RESEARCH, 2005

    Expression of the bcl-6 and MUM1

    JOURL OF CUTANEOUS PATHOLOGY, 2005

    Short tandem repeat alysis to monitor chimerism in Macaca fascicularis

    AMERICAN JOURL OF TRANSPLANTATION, 2004

    Extranodal nonorbital indolent lymphomas of the head and neck

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

    CD30(+) cutaneous lymphoproliferative disorders

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003

    Rituximab in lymphocyte-predomint Hodgkin disease: results of a phase 2 trial

    BLOOD, 2003

    Gene expression profiles of cutaneous B cell lymphoma

    JOURL OF INVESTIGATIVE DERMATOLOGY, 2003

    Topical nitrogen mustard in the magement of mycosis fungoides - Update of the Stanford experience

    ARCHIVES OF DERMATOLOGY, 2003

    Hodgkin's disease: A model for interdiscipliry cancer magement: 2002 Janeway Lecture

    CANCER JOURL, 2002

    Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2002

    Primary radiotherapy for localized orbital malt lymphoma

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002

    Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease

    JOURL OF CLINICAL ONCOLOGY, 2002

    tural killer/tural killer

    JOURL OF CLINICAL ONCOLOGY, 2001

    Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides

    JOURL OF CLINICAL ONCOLOGY, 2001

    Long-term follow-up of patients with Stage III follicular lymphoma treated with primary

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001

    Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced

    JOURL OF CLINICAL ONCOLOGY, 2000

    Magement of breast cancer after Hodgkin's disease

    Wolden, S. L., Hancock, S. L., Carlson, R. W., Goffinet, D. R., Jeffre, 2000

    What is the significance of sal involvement in sopharyngeal carcinoma?

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999

    The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.

    cancer jourl from Scientific American, 1999

    Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999

    Mycosis fungoides and the Sezary syndrome

    SEMIRS IN ONCOLOGY, 1999

    Results of the 1988-1989 patterns of care study process survey for Hodgkin's disease

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999

    Role of histology in providing prognostic information in mycosis fungoides

    JOURL OF CUTANEOUS PATHOLOGY, 1998

    Mycosis fungoides in young patients: Clinical characteristics and outcome

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998

    Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease.

    Anls of oncology, 1998

    Fractioted total-body irradiation, etoposide

    Biology of blood and marrow transplantation, 1997

    Long-term depletion of ive T cells in patients treated for Hodgkin's disease

    BLOOD, 1997

    Non-Hodgkin's lymphoma of the parasal sinuses

    CANCER JOURL, 1997

    Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease

    JOURL OF CLINICAL ONCOLOGY, 1997

    Comparison between conventiol salvage therapy

    BLOOD, 1997

    Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease.

    Semirs in radiation oncology, 1997

    Gastrointestil cancer after treatment of Hodgkin's disease

    Birdwell, S. H., Hancock, S. L., Varghese, A., Cox, R. S., Hoppe, R. T, 1997

    Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome alysis

    ARCHIVES OF DERMATOLOGY, 1996

    High-dose therapy and autologous bone marrow transplantation for relapsed

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996

    Is radiotherapy curative for stage I

    JOURL OF CLINICAL ONCOLOGY, 1996

    Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclol antibody

    BLOOD, 1996

    Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.

    Semirs in radiation oncology, 1996

    MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MAGEMENT OF MYCOSIS-FUNGOIDES

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995

    PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995

    BRIEF CHEMOTHERAPY, STANFORD-V

    JOURL OF CLINICAL ONCOLOGY, 1995

    CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995

    FRACTIOTED TOTAL-BODY IRRADIATION, ETOPOSIDE

    JOURL OF CLINICAL ONCOLOGY, 1994

    TREATMENT OF EARLY-STAGE GASTRIC LYMPHOMA

    JOURL OF SURGICAL ONCOLOGY, 1994

    EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMORY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY

    JOURL OF CLINICAL ONCOLOGY, 1994

    EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994

    FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE

    JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 1993

    CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS

    JOURL OF CLINICAL ONCOLOGY, 1993

    MR-IMAGING TO DETECT CHEST

    AMERICAN JOURL OF ROENTGENOLOGY, 1993

    HODGKINS-DISEASE WITH BULKY MEDIASTIL INVOLVEMENT

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993

    MYCOSIS-FUNGOIDES - CLINICAL AND HISTOLOGIC FEATURES, STAGING

    CA-A CANCER JOURL FOR CLINICIANS, 1993

    BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE

    JOURL OF THE TIOL CANCER INSTITUTE, 1993

    THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE

    ANLS OF ONCOLOGY, 1992

    THE MAGEMENT OF HODGKINS-DISEASE IN RELAPSE AFTER PRIMARY RADIATION-THERAPY

    EUROPEAN JOURL OF CANCER, 1992

    METASTATIC CARCINOMA IN LYMPH-NODES SIMULATING SYNCYTIAL VARIANT OF NODULAR SCLEROSING HODGKINS

    AMERICAN JOURL OF CLINICAL PATHOLOGY, 1991

    THE MAGEMENT OF MYCOSIS-FUNGOIDES AT STANFORD - STANDARD AND INNOVATIVE TREATMENT PROGRAMS

    Hoppe, R. T., 1991

    TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1991

    OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLOL

    BLOOD, 1991

    THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE

    ANLS OF ONCOLOGY, 1991

    TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MAGEMENT OF MYCOSIS-FUNGOIDES

    Hoppe, R. T., 1991

    RADIATION-THERAPY IN THE MAGEMENT OF HODGKINS-DISEASE

    SEMIRS IN ONCOLOGY, 1990

    DISCORDANT EXPRESSION OF ANTIGENS BETWEEN INTRAEPIDERMAL AND INTRADERMAL T-CELLS IN MYCOSIS

    AMERICAN JOURL OF PATHOLOGY, 1990

    RADIATION-THERAPY IN THE MAGEMENT OF BULKY MEDIASTIL HODGKINS-DISEASE

    BEHAR, R. A., Hoppe, R. T., 1990

    LEU-8/CD7 ANTIGEN EXPRESSION BY CD3+ T-CELLS - COMPARATIVE-ALYSIS OF SKIN AND BLOOD IN

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990

    PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE

    JOURL OF CLINICAL ONCOLOGY, 1990

    Bone marrow transplantation for hematologic maligncies: the Stanford experience.

    Clinical transplants, 1990

    CUTANEOUS LYMPHOID HYPERPLASIA

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989

    OUTCOME OF THE ACUTE GLOMERULAR INJURY IN PROLIFERATIVE LUPUS NEPHRITIS

    JOURL OF CLINICAL INVESTIGATION, 1989

    ACQUIRED IMMUNE TOLERANCE TO CADAVERIC REL-ALLOGRAFTS

    NEW ENGLAND JOURL OF MEDICINE, 1989

    EXPRESSION OF T-CELL RECEPTOR ANTIGENS IN MYCOSIS-FUNGOIDES AND INFLAMMATORY SKIN-LESIONS

    JOURL OF INVESTIGATIVE DERMATOLOGY, 1989

    CLOL REARRANGEMENTS OF IMMUNOGLOBULIN GENES AND PROGRESSION TO B

    AMERICAN JOURL OF PATHOLOGY, 1989

    THE MAGEMENT OF BULKY MEDIASTIL HODGKINS-DISEASE

    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1989

    CHARACTERIZATION OF SPLENIC STRUCTURE IN HODGKIN DISEASE BY USING RROW

    AMERICAN JOURL OF ROENTGENOLOGY, 1989

    SMALL LYMPHOCYTIC LYMPHOMA

    JOURL OF CLINICAL ONCOLOGY, 1989

    DETECTION OF CLOL T-CELL RECEPTOR GENE REARRANGEMENTS IN THE PERIPHERAL

    JOURL OF INVESTIGATIVE DERMATOLOGY, 1989

    NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT

    RADIOLOGY, 1989

    PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I

    JOURL OF CLINICAL ONCOLOGY, 1989

    VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE

    JOURL OF CLINICAL ONCOLOGY, 1988

    BENIGN AND MALIGNT FORMS OF ERYTHRODERMA - CUTANEOUS IMMUNOPHENOTYPIC CHARACTERISTICS

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988

    THE CONTEMPORARY MAGEMENT OF HODGKIN DISEASE

    RADIOLOGY, 1988

    COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988

    INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS

    ANLS OF INTERL MEDICINE, 1988

    CLINICAL AND IMMUNOLOGICAL STUDIES OF CADAVERIC REL-TRANSPLANT RECIPIENTS GIVEN TOTAL

    TRANSPLANTATION, 1988

    NODULAR AND DIFFUSE TYPES OF LYMPHOCYTE PREDOMINCE HODGKINS-DISEASE

    NEW ENGLAND JOURL OF MEDICINE, 1988

    T-CELL ANTIGEN DEFICIENCIES AND CLOL REARRANGEMENTS OF T

    NEW ENGLAND JOURL OF MEDICINE, 1988

    SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL

    JOURL OF CLINICAL ONCOLOGY, 1987

    LUPUS NEPHRITIS AFTER TOTAL LYMPHOID IRRADIATION - PERSISTENT IMPROVEMENT AND REDUCTION OF STEROID

    ANLS OF INTERL MEDICINE, 1987

    MYCOSIS-FUNGOIDES - MAGEMENT WITH TOPICAL NITROGEN-MUSTARD

    JOURL OF CLINICAL ONCOLO

    STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

    JOURNAL OF CLINICAL ONCOLOGY, 2010

    TLI and ATG conditioning with low risk of graft-versus

    BLOOD, 2009

    Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells

    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009

    Prognostic Factors in Primary Cutaneous Anapl

    ARCHIVES OF DERMATOLOGY, 2009

    Low Stage Follicular Lymphoma

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009

    Dynamic CD8 T-Cell Responses to Tumor

    ONCOLOGY RESEARCH, 2009

    Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008

    Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008

    Hodgkin disease/lymphoma.

    Journal of the National Comprehensive Cancer Network, 2008

    Tolerance and chimerism after renal and hematopoietic-cell transplantation.

    New England journal of medicine, 2008

    Hodgkin's lymphoma: The role of radiation in the modern combined strategies of treatment

    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007

    Impact of positive positron emission tomography on prediction of freedom from progression after

    JOURNAL OF CLINICAL ONCOLOGY, 2007

    TNM classification system for primary cutaneous lymphomas other than mycosis fungoides

    BLOOD, 2007

    Revised response criteria for malignant lymphoma

    JOURNAL OF CLINICAL ONCOLOGY, 2007

    Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease

    JOURNAL OF CLINICAL ONCOLOGY, 2007

    Second lymphomas and other malignant neoplasms

    ARCHIVES OF DERMATOLOGY, 2007

    Staging accuracy in mycosis fungoides

    ARCHIVES OF DERMATOLOGY, 2006

    Protective conditioning for acute graft-versus-host disease

    NEW ENGLAND JOURNAL OF MEDICINE, 2005

    A technique of bone marrow collection from vertebral bodies of cynomolgus macaques

    JOURNAL OF SURGICAL RESEARCH, 2005

    Expression of the bcl-6 and MUM1

    JOURNAL OF CUTANEOUS PATHOLOGY, 2005

    Short tandem repeat analysis to monitor chimerism in Macaca fascicularis

    AMERICAN JOURNAL OF TRANSPLANTATION, 2004

    Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting

    ARCHIVES OF DERMATOLOGY, 2004

    Extranodal nonorbital indolent lymphomas of the head and neck

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

    CD30(+) cutaneous lymphoproliferative disorders

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003

    Long-term outcome of 525 patients with mycosis fungoides

    ARCHIVES OF DERMATOLOGY, 2003

    Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

    BLOOD, 2003

    Gene expression profiles of cutaneous B cell lymphoma

    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003

    Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience

    ARCHIVES OF DERMATOLOGY, 2003

    Mycosis fungoides: radiation therapy.

    Dermatologic therapy, 2003

    Hodgkin's disease: A model for interdisciplinary cancer management: 2002 Janeway Lecture

    CANCER JOURNAL, 2002

    Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients

    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002

    Mixed chimerism and immunosuppressive drug withdrawal after HLA

    TRANSPLANTATION, 2002

    Primary radiotherapy for localized orbital malt lymphoma

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002

    Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease

    JOURNAL OF CLINICAL ONCOLOGY, 2002

    NCCN: Non-Hodgkin's lymphoma.

    Zelenetz, A. D., Hoppe, R. T.

    Natural killer/natural killer

    JOURNAL OF CLINICAL ONCOLOGY, 2001

    Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides

    JOURNAL OF CLINICAL ONCOLOGY, 2001

    High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first

    BLOOD, 2001

    High-dose therapy and autologous hematopoietic

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001

    Long-term follow-up of patients with Stage III follicular lymphoma treated with primary

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001

    Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced

    JOURNAL OF CLINICAL ONCOLOGY, 2000

    Management of breast cancer after Hodgkin's disease

    Wolden, S. L., Hancock, S. L., Carlson, R. W., Goffinet, D. R., Jeffre, 2000

    Toxicity of high-dose sequential chemotherapy

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000

    What is the significance of nasal involvement in nasopharyngeal carcinoma?

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999

    The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.

    cancer journal from Scientific American, 1999

    Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999

    Mycosis fungoides and the Sezary syndrome

    SEMINARS IN ONCOLOGY, 1999

    Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen

    Chinn, D. M., Chow, S., Kim, Y. H., Hoppe, R. T., 1999

    Results of the 1988-1989 patterns of care study process survey for Hodgkin's disease

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999

    Clinical characteristics and long-term outcome of patients with generalized patch and

    ARCHIVES OF DERMATOLOGY, 1999

    Role of histology in providing prognostic information in mycosis fungoides

    JOURNAL OF CUTANEOUS PATHOLOGY, 1998

    Mycosis fungoides in young patients: Clinical characteristics and outcome

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998

    Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease.

    Annals of oncology, 1998

    Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection

    Wolden, S. L., Tate, D. J., Hunt, S. A., Strober, S., Hoppe, R. T., 1997

    Fractionated total-body irradiation, etoposide

    Biology of blood and marrow transplantation, 1997

    Long-term depletion of naive T cells in patients treated for Hodgkin's disease

    BLOOD, 1997

    Non-Hodgkin's lymphoma of the paranasal sinuses

    CANCER JOURNAL, 1997

    Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease

    JOURNAL OF CLINICAL ONCOLOGY, 1997

    Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies

    TORREY, M. J., Poen, J. C., Hoppe, R. T., 1997

    Comparison between conventional salvage therapy

    BLOOD, 1997

    High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or

    BLOOD, 1997

    Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease.

    Seminars in radiation oncology, 1997

    Hodgkin's disease: Complications of therapy and excess mortality

    Hoppe, R. T., 1997

    Gastrointestinal cancer after treatment of Hodgkin's disease

    Birdwell, S. H., Hancock, S. L., Varghese, A., Cox, R. S., Hoppe, R. T, 1997

    Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis

    ARCHIVES OF DERMATOLOGY, 1996

    High-dose therapy and autologous bone marrow transplantation for relapsed

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996

    Influence of preparatory regimen

    Biology of blood and marrow transplantation, 1996

    Is radiotherapy curative for stage I

    JOURNAL OF CLINICAL ONCOLOGY, 1996

    Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody

    BLOOD, 1996

    Hodgkin's disease - The role of radiation therapy in advanced disease

    Hoppe, R. T., 1996

    Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease

    Horning, S. J., Rosenberg, S. A., Hoppe, R. T., 1996

    Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.

    Seminars in radiation oncology, 1996

    PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME

    ARCHIVES OF DERMATOLOGY, 1995

    MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995

    PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995

    BRIEF CHEMOTHERAPY, STANFORD-V

    JOURNAL OF CLINICAL ONCOLOGY, 1995

    CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995

    FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE

    JOURNAL OF CLINICAL ONCOLOGY, 1994

    TREATMENT OF EARLY-STAGE GASTRIC LYMPHOMA

    JOURNAL OF SURGICAL ONCOLOGY, 1994

    EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMONARY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY

    JOURNAL OF CLINICAL ONCOLOGY, 1994

    EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994

    FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993

    CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS

    JOURNAL OF CLINICAL ONCOLOGY, 1993

    MR-IMAGING TO DETECT CHEST

    AMERICAN JOURNAL OF ROENTGENOLOGY, 1993

    HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993

    MYCOSIS-FUNGOIDES - CLINICAL AND HISTOLOGIC FEATURES, STAGING

    CA-A CANCER JOURNAL FOR CLINICIANS, 1993

    BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE

    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993

    SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME AFTER TREATMENT FOR HODGKINS-DISEASE

    Hoppe, R. T., 1992

    THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE

    ANNALS OF ONCOLOGY, 1992

    THE MANAGEMENT OF HODGKINS-DISEASE IN RELAPSE AFTER PRIMARY RADIATION-THERAPY

    EUROPEAN JOURNAL OF CANCER, 1992

    COMBINED-MODALITY THERAPY FOR THE TREATMENT OF HODGKINS-DISEASE

    Hoppe, R. T., 1992

    METASTATIC CARCINOMA IN LYMPH-NODES SIMULATING SYNCYTIAL VARIANT OF NODULAR SCLEROSING HODGKINS

    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991

    THE MANAGEMENT OF MYCOSIS-FUNGOIDES AT STANFORD - STANDARD AND INNOVATIVE TREATMENT PROGRAMS

    Hoppe, R. T., 1991

    TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION

    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1991

    OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL

    BLOOD, 1991

    THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE

    ANNALS OF ONCOLOGY, 1991

    TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES

    Hoppe, R. T., 1991

    RADIATION-THERAPY IN THE MANAGEMENT OF HODGKINS-DISEASE

    SEMINARS IN ONCOLOGY, 1990

    DISCORDANT EXPRESSION OF ANTIGENS BETWEEN INTRAEPIDERMAL AND INTRADERMAL T-CELLS IN MYCOSIS

    AMERICAN JOURNAL OF PATHOLOGY, 1990

    Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.

    Current problems in cancer, 1990

    RADIATION-THERAPY IN THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE

    BEHAR, R. A., Hoppe, R. T., 1990

    LEU-8/CD7 ANTIGEN EXPRESSION BY CD3+ T-CELLS

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990

    PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE

    JOURNAL OF CLINICAL ONCOLOGY, 1990

    Bone marrow transplantation for hematologic malignancies: the Stanford experience.

    Clinical transplants, 1990

    CUTANEOUS LYMPHOID HYPERPLASIA

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989

    OUTCOME OF THE ACUTE GLOMERULAR INJURY IN PROLIFERATIVE LUPUS NEPHRITIS

    JOURNAL OF CLINICAL INVESTIGATION, 1989

    ACQUIRED IMMUNE TOLERANCE TO CADAVERIC RENAL-ALLOGRAFTS

    NEW ENGLAND JOURNAL OF MEDICINE, 1989

    EXPRESSION OF T-CELL RECEPTOR ANTIGENS IN MYCOSIS-FUNGOIDES AND INFLAMMATORY SKIN-LESIONS

    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989

    CLONAL REARRANGEMENTS OF IMMUNOGLOBULIN GENES AND PROGRESSION TO B

    AMERICAN JOURNAL OF PATHOLOGY, 1989

    THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE

    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1989

    CHARACTERIZATION OF SPLENIC STRUCTURE IN HODGKIN DISEASE BY USING NARROW

    AMERICAN JOURNAL OF ROENTGENOLOGY, 1989

    SMALL LYMPHOCYTIC LYMPHOMA

    JOURNAL OF CLINICAL ONCOLOGY, 1989

    DETECTION OF CLONAL T-CELL RECEPTOR GENE REARRANGEMENTS IN THE PERIPHERAL

    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989

    NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT

    RADIOLOGY, 1989

    EFFECTS OF IRRADIATION ON THE HUMAN IMMUNE-SYSTEM

    Hoppe, R. T., 1989

    Current Stanford clinical trials for Hodgkin's disease.

    Recent results in cancer research. Fortschritte der Krebsforschung. Pr, 1989

    PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I

    JOURNAL OF CLINICAL ONCOLOGY, 1989

    VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE

    JOURNAL OF CLINICAL ONCOLOGY, 1988

    BENIGN AND MALIGNANT FORMS OF ERYTHRODERMA - CUTANEOUS IMMUNOPHENOTYPIC CHARACTERISTICS

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988

    THE CONTEMPORARY MANAGEMENT OF HODGKIN DISEASE

    RADIOLOGY, 1988

    COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988

    INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS

    ANNALS OF INTERNAL MEDICINE, 1988

    TREATMENT OF LUPUS NEPHRITIS WITH TOTAL LYMPHOID IRRADIATION - OBSERVATIONS DURING A 12

    ARTHRITIS AND RHEUMATISM, 1988

    CLINICAL AND IMMUNOLOGICAL STUDIES OF CADAVERIC RENAL-TRANSPLANT RECIPIENTS GIVEN TOTAL

    TRANSPLANTATION, 1988

    POIKILODERMATOUS MYCOSIS-FUNGOIDES AND ATROPHIC LARGE

    ARCHIVES OF DERMATOLOGY, 1988

    NODULAR AND DIFFUSE TYPES OF LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE

    NEW ENGLAND JOURNAL OF MEDICINE, 1988

    T-CELL ANTIGEN DEFICIENCIES AND CLONAL REARRANGEMENTS OF T

    NEW ENGLAND JOURNAL OF MEDICINE, 1988

    DISSECTION OF THE MECHANISMS OF IMMUNE INJURY IN RHEUMATOID-ARTHRITIS

    ARTHRITIS AND RHEUMATISM, 1988

    The non-Hodgkin's lymphomas: pathology, staging, treatment.

    Current problems in cancer, 1987

    SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL

    JOURNAL OF CLINICAL ONCOLOGY, 1987

    LUPUS NEPHRITIS AFTER TOTAL LYMPHOID IRRADIATION - PERSISTENT IMPROVEMENT AND REDUCTION OF STEROID

    ANNALS OF INTERNAL MEDICINE, 1987

    MYCOSIS-FUNGOIDES - MANAGEMENT WITH TOPICAL NITROGEN-MUSTARD

    JOURNAL OF CLINICAL ONCOLO

    What is Dr. Hoppe's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Hoppe's National Provider Identifier (NPI) number is 1730221821.

    What common questions do patients ask about Dr. Hoppe?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Hoppe

    What is Dr. Richard Hoppe's specialty?

    Dr. Hoppe is a Radiation Oncologist near Pleasanton, CA. A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors. Contact Dr. Hoppe to book an appointment today.

    Is this Dr. Richard Hoppe affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Hoppe is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Radiation Oncologist?

    Explore Radiation Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Richard Hoppe accepting new patients in Pleasanton, CA?

    Yes, Dr. Richard Hoppe is accepting new patients at this time.

    Does Dr. Richard Hoppe offer online booking?

    Please contact Dr. Hoppe's office for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Richard Hoppe?

    Please contact Dr. Hoppe's office for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Richard Hoppe have?

    Dr. Richard Hoppe is certified by the American Board of Radiology.

    Other Radiation Oncologist Near Pleasanton, CA

    SH

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Pleasanton, CA
    SZ

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Pleasanton, CA
    MG

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Pleasanton, CA
    See All Specialists

    Doctors by Category

    Specialists